跳至主要内容
临床试验/NCT06019455
NCT06019455招募中不适用

A Prospective Observational Study on the Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.

Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
Incidence of >=Grade 3 toxicities

研究概览

简要总结

This study aims to assess the level of participation of thoracic cancer patients undergoing definitive radiotherapy and chemotherapy ± immunotherapy in their medical processes and the association between the level of participation and patients' side effects, quality of life, and long-term survival. Additionally, this study will rate the level of participation from both the patients' and medical staff's perspectives and will compare the differences in ratings from these two viewpoints, as well as their impact on treatment outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Locally advanced non-small cell lung cancer, limited-stage small cell lung cancer, and esophageal cancer.
  • Planned to undergo definitive chemoradiotherapy ± immunotherapy;
  • Males or females aged 18 to 75;
  • Able to communicate with medical staff.

排除标准

  • Patients with cognitive impairments.

结局指标

主要结局

Incidence of >=Grade 3 toxicities

时间窗: 2 years

The percentage of patients who develop \>=Grade 3 toxicities

次要结局

  • Overall survival(2 years)
  • Progression-free survival(2 years)

研究者

发起方
Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hui Liu

Professor

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验

The Level of Patient Participation in Lung and... | 临床试验